Considering the coexistence of neuropeptide Y (NPY) and norepinephrine in p
erivascular sympathetic nerves and the known vasoconstrictor cooperation of
NPY with norepinephrine, we investigated the involvement of NPY in long-te
rm control of cardiovascular functions using NPY transgenic (NPY-tg) rats.
These rats were developed by injection of the rat (Sprague-Dawley) pronucle
i with a 14.5-kb clone of the rat structural NPY gene. When compared with n
ontransgenic littermates, NPY concentrations were significantly increased i
n a number of cardiovascular tissues of NPY-tg hemizygotes. Direct basal me
an arterial pressure and heart rate were not changed, but calculated total
vascular resistance was significantly increased in NPY-tg subjects. Arteria
l pressure increases, in response to norepinephrine injection, were greater
in the NPY-tg rats. Also, the hypotension and bradycardia in response to h
emorrhage were significantly reduced in NPY-tg subjects. These results indi
cate that NPY, when expressed in increased amounts, potentiates the pressor
effects of norepinephrine and contributes to maintaining blood pressure du
ring hemorrhage, but it does not alter resting blood pressure. These transg
enic rats will facilitate studies of the role of NPY signaling in cardiovas
cular regulation, particularly regarding its functional cooperation with no
repinephrine.